Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

BUY
$4.21 - $11.15 $332 - $880
79 Added 31.35%
331 $2,000
Q1 2022

May 13, 2022

BUY
$8.48 - $18.1 $364 - $778
43 Added 20.57%
252 $3,000
Q4 2021

Feb 11, 2022

SELL
$15.37 - $22.5 $169 - $247
-11 Reduced 5.0%
209 $4,000
Q3 2021

Feb 11, 2022

SELL
$15.05 - $23.28 $1,610 - $2,490
-107 Reduced 32.72%
220 $4,000
Q2 2021

Feb 11, 2022

BUY
$15.31 - $24.63 $5,006 - $8,054
327 New
327 $6,000

Others Institutions Holding TIL

About Instil Bio, Inc.


  • Ticker TIL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 129,694,000
  • Market Cap $2.57B
  • Description
  • Instil Bio, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of patients with cancer. The company develops cell therapy of autologous tumor infiltrating lymphocyte (TIL). Its TIL product candidates in pipeline include ITIL-168 for indications, such as melanoma, cutaneous squamous cell carcinoma, non-small ce...
More about TIL
Track This Portfolio

Track State Of Wyoming Portfolio

Follow State Of Wyoming and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Of Wyoming, based on Form 13F filings with the SEC.

News

Stay updated on State Of Wyoming with notifications on news.